Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:2
  • preuzimanja u poslednjih 30 dana:0

Sadržaj

članak: 8 od 12  
Back povratak na rezultate
2017, vol. 74, br. 9, str. 831-839
Procena uticaja hipoglikemije i indeksa telesne mase na kvalitet života kod obolelih od šećerne bolesti tipa 2
General Hospital of Leskovac, Leskovac

e-adresamarijastojiljkovic986@gmail.com
Sažetak
Uvod/Cilj. Noviji podaci sugerišu da gojazne osobe sa dijabetesom tip 2 (DMT2) češće imaju lošiju kontrolu glikemije i češće komplikacije poput neuropatije, kao i višu stopu mortaliteta u odnosu na obolele od dijabetesa sa normalnom telesnom masom. Cilj istraživanja bio je da se utvrdi učestalost hipoglikemijskih epizoda, odredi vrednost indeksa telesne mase (ITM) i proceni njihov uticaj na kvalitet života (QL) kod obolelih od DMT2 korišćenjem upitnika EuroQoL-EQ 5-dimensional (EQ-5D) nakon korekcije za starost, trajanje dijabetesa melitusa i prisustvo kasnih komplikacija bolesti. Metode. Ovom kliničko-epidemiološkom studijom preseka obuhvaćena su 269 uzastopno selektovana bolesnika oba pola, sa postavljenom dijagnozom DMT2 trajanja dužeg od jedne godine. Standardizovana verzija upitnika EQ-5D trećeg nivoa - EQ-5D-3L na srpskom jeziku i EQ vizuelna analogna skala (EQ-VAS) korišćeni su za procenu kvaliteta života u vezi sa zdravljem. Rezultati. Prosečna starost ispitanika iznosila je 65,1 ± 9,3 godina. Hipoglikemija je zabeležena kod 71%, gojaznost kod 43.9% i hronične komplikacije kod 88.8% isptanika. Polovina bolesnika nije dostigla ciljne vrednosti glikoziliranog hemoglobina (HbA1c) (HbA1c < 7%). Hipoglikemija je bila značajno češća kod mlađih bolesnika u trenutku postavljanja dijagnoze (54,19 vs 57,59) a ređa kod visokobrazovanih ispitanika (7,3% vs 35,1%). Bolesnici sa hipoglikemijom imali su veću ocenu za bol i nelagodnost (1,86 vs 1,68) u EQ-5D upitniku, niže vrednosti VAS skora (55,99 vs 62,44) i EQ-5D indeksa (0,85 vs 0,87) u odnosu na one sa dobrom kontrolom glikemije. Gojazni ispitanici su uglavnom bili ženskog pola, sa povišenim vrednostima sistolnog i dijastolnog pritiska, povišenim trigliceridima, obimom struka, ocenom za anksioznost i depresiju (2,01 vs 1,80) i većim brojem epizoda hipoglikemija na godišnjem nivou. Nakon korekcije za doprinoseće faktore, ispitanici sa hipoglikemijom imali su 2 035 puta veću šansu za teži stepen bola i nelagodnosti. Sa povećanjem ITM, šansa za probleme mobilnosti, anksioznost/depresiju povećala se 1,05 puta. Hipoglikemija je bila značajno povezana sa nižim vrednostima VAS skora (b = -0.13). Povećanje vrednosti ITM bilo je statistički značajno povezano sa nižim vrednostima EQ 5D indeksa (b = -1,78). Učestalost hipoglikemije nije bila povezana sa vrednostima VAS skorom i EQ 5D indeksa. Zaključak. Rezultati su pokazali značajnu povezanost hipoglikemije i gojaznosti sa smanjenim QL, procenjenim na osnovu EQ-5D upitnika. Korekcija životnih stilova usmerenih ka smanjenju gojaznosti i hipoglikemije uz optimalnu terapiju, može značajno poboljšati QL vezan za zdravlje kod bolesnika sa DMT2.
Reference
*** (2011) Incidence and mortality of diabetes in Serbia 2011. Belgrade: Institute of Public Health of Serbia Dr Milan Jovanovic Batut, Serbian Diabetes Registry Report N. 6. (Serbian)
Abate, N. (2000) Obesity and cardiovascular disease. Journal of Diabetes and its Complications, 14(3): 154-174
American Diabetes Association Workgroup on Hypoglycemia (2005) Defining and Reporting Hypoglycemia in Diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care, 28(5): 1245-1249
Amiel, S. A., Dixon, T., Mann, R., Jameson, K. (2008) Hypoglycaemia in Type 2 diabetes. Diabetic Medicine, 25(3): 245-254
Brazier, J., Roberts, J., Deverill, M. (2002) The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2): 271-292
Dennett, S.L., Boye, K.S., Yurgin, N.R. (2008) The Impact of Body Weight on Patient Utilities with or without Type 2 Diabetes: A Review of the Medical Literature. Value in Health, 11(3): 478-486
Donnelly, L. A., Morris, A. D., Frier, B. M., Ellis, J. D., Donnan, P. T., Durrant, R., Band, M. M., Reekie, G., Leese, G. P. (2005) Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabetic Medicine, 22(6): 749-755
El-Kebbi, I.M., Cook, C.B., Ziemer, D.C., Miller, C.D., Gallina, D.L., Phillips, L.S. (2003) Association of Younger Age With Poor Glycemic Control and Obesity in Urban African Americans With Type 2 Diabetes. Archives of Internal Medicine, 163(1): 69
Grandy, S., Chapman, R. H., Fox, K. M. (2008) Quality of life and depression of people living with type 2 diabetes mellitus and those at low and high risk for type 2 diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). International Journal of Clinical Practice, 62(4): 562-568
Grandy, S., Fox, K.M. (2008) EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Health and Quality of Life Outcomes, 6(1): 18
Greiner, W., Claes, C., Busschbach, J. J. V., Graf, von der S.J.-M. (2005) Validating the EQ-5D with time trade off for the German population. European Journal of Health Economics, 6(2): 124-130
Guariguata, L., Whiting, D.R., Hambleton, I., Beagley, J., Linnenkamp, U., Shaw, J.E. (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Research and Clinical Practice, 103(2): 137-149
Heintz, E., Wiréhn, A., Peebo, B.B., Rosenqvist, U., Levin, L. (2012) QALY Weights for Diabetic Retinopathy-A Comparison of Health State Valuations with HUI-3, EQ-5D, EQ-VAS, and TTO. Value in Health, 15(3): 475-484
Hunger, M., Schunk, M., Meisinger, C., Peters, A., Holle, R. (2012) Estimation of the relationship between body mass index and EQ-5D health utilities in individuals with type 2 diabetes: Evidence from the population-based KORA studies. Journal of Diabetes and its Complications, 26(5): 413-418
Ji, L., Zou, D., Liu, L., Qian, L., Kadziola, Z., Babineaux, S., Zhang, H.N., Wood, R. (2015) Increasing body mass index identifies Chinese patients with type 2 diabetes mellitus at risk of poor outcomes. Journal of Diabetes and its Complications, 29(4): 488-496
Lee, W.J., Song, K., Noh, J.H., Choi, Y.J., Jo, M. (2012) Health-Related Quality of Life Using the EuroQol 5D Questionnaire in Korean Patients with Type 2 Diabetes. Journal of Korean Medical Science, 27(3): 255
Litwak, L., Goh, S., Hussein, Z., Malek, R., Prusty, V., Khamseh, M.E. (2013) Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study. Diabetology & Metabolic Syndrome, 5(1): 57
Lundkvist, J., Berne, C., Bolinder, B., Jönsson, L. (2005) The economic and quality of life impact of hypoglycemia. European Journal of Health Economics, 6(3): 197-202
Miranda-Massari, J.R., Gonzalez, M.J., Fernando, A.S., Cidre, C., Paz, I.M., Charvel, J., i dr. (2015) Metabolic Correction as a tool to improve diabetes type 2 management. Bol Asoc Med P R, 107(2); 54-9
Nguyen, N.T., Nguyen, X.T., Lane, J., Wang, P. (2011) Relationship Between Obesity and Diabetes in a US Adult Population: Findings from the National Health and Nutrition Examination Survey, 1999-2006. Obesity Surgery, 21(3): 351-355
Pettersson, B., Rosenqvist, U., Deleskog, A., Journath, G., Wändell, P. (2011) Self-reported experience of hypoglycemia among adults with type 2 diabetes mellitus (Exhype). Diabetes Research and Clinical Practice, 92(1): 19-25
Pickering, T. G. (2005) Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 1: Blood Pressure Measurement in Humans: A Statement for Professionals From the Subcommittee of Professional and Public Education of the American Heart Associatio. Circulation, 111(5): 697-716
Rabin, R., Charro, F. (2001) EQ-5D: a measure of health status from the EuroQol Group. Annals of medicine, 33(5): 337-43
Rodbard, H.W., Jellinger, P.S., Davidson, J.A., Einhorn, D., Garber, A.J., Grunberger, G., Handelsman, Y., Horton, E.S., Lebovitz, H., Levy, P., Moghissi, E.S., Schwartz, S.S. (2009) Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: An algorithm for glycemic control. Endocrine practice, 15(6): 540-59
Schram, M., Baan, C., Pouwer, F. (2009) Depression and Quality of Life in Patients with Diabetes: A Systematic Review from the European Depression in Diabetes (EDID) Research Consortium. Current Diabetes Reviews, 5(2): 112-119
Stargardt, T., Gonder-Frederick, L., Krobot, K.J., Alexander, C.M. (2009) Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes. Health and Quality of Life Outcomes, 7(1): 91
Tamayo, T., Rosenbauer, J., Wild, S.H., Spijkerman, A.M.W., Baan, C., Forouhi, N.G., Herder, C., Rathmann, W. (2014) Diabetes in Europe: An update. Diabetes Research and Clinical Practice, 103(2): 206-217
UKPDS (1983) UK prospective study of therapies of maturity-onset diabetes. I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year. Diabetologia, 24(6); 404-11
Vexiau, P., Mavros, P., Krishnarajah, G., Lyu, R., Yin, D. (2008) Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes, Obesity and Metabolism, 10(s1): 16-24
Wang, C., Lin, C., Huang, T., Chien, M., Hsieh, S., Huang, Y., Shih, K., Tu, S., Chang, C., Chien-Ning, H., Chou, C., Wu, T., Liu, R., Lam, H., Kwok, C. (2012) Inertia on hypoglycemia: Highlight from a Taiwan subgroup analysis of Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study. Diabetes Research and Clinical Practice, 98(1): 61-67
WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. Geneva. WHO Technical Report Series, 894
Williams, S.A., Pollack, M.F., DiBonaventura, M. (2011) Effects of hypoglycemia on health-related quality of life, treatment satisfaction and healthcare resource utilization in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice, 91(3): 363-370
 

O članku

jezik rada: engleski
vrsta rada: izvorni naučni članak
DOI: 10.2298/VSP151222098C
objavljen u SCIndeksu: 02.10.2017.
metod recenzije: dvostruko anoniman
Creative Commons License 4.0